J1573
J1573 – Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 2 NDCs crosswalked per 0.5 ML $65.610/unit ASP+6%
📋 J1573 summary
J1573 is a HCPCS Level II J-code used to bill hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml, billed per 0.5 ML. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J1573: Hepagam B(J1573), Hepagam B
Code J1573
Billing unit 0.5 ML Payment limit $65.610/unit NDC-Crosswalk 2
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ1573
DescriptorInjection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
Billing unit0.5 ML
Payment limit / unit$65.610
Est. ASP / unit$61.896 est.
Mapped NDCs2
Data periodQ3 2026
Last updated2026-08-20
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$65.610
Est. ASP / unit
$61.896 est.
Est. after 2% sequester
$64.298
HCPCS dosage
0.5 ML
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeN — No maintenance this year
Effective date2009-01-01
Date added2008-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J1573 = 0.5 ml. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J1573 WITH EST. MEDICARE PAY
2 NDCs map to J1573. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($65.610/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 49591-0051-51 | HepaGam B HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN 312 [iU]/mL INJECTION, SOLUTION | Kamada | 1 VIAL, GLASS in 1 CARTON (49591-051-51)... | 312 [iU]/mL | 10 | $656.10 | — | ● Active | CMS ASP |
| 49591-0052-51 | HepaGam B HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN 312 [iU]/mL INJECTION, SOLUTION | Kamada | 1 VIAL, GLASS in 1 CARTON (49591-052-51)... | 312 [iU]/mL | 2 | $131.22 | — | ● Active | CMS ASP |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$68.1K
Claims
24
Beneficiaries
16
Spend / beneficiary
$4,254.05
Spend / claim
$2,836.03
Trend by period
Where J1573 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #593 of 824
#588
REVITA, PER SQ CM** Q4180
$71.6K
#589
SODIUM CHLORIDE(J705... J7050
$71.5K
#590
FOSAPREPITANT DIMEGL... J1456
$70.3K
#591
AMNIOWRAP2 PER SQ CM... Q4221
$70.1K
#592
PROHANCE MULTIPACK A9576
$69.9K
#593
HEPAGAM B(J1573) J1573
$68.1K
#594
LUMASON Q9950
$68K
#595
AFLURIA (90658)* 90658
$65.9K
#596
PREDNISONE INTENSOL* J7512
$63.9K
#597
BIOVANCE 1 SQUARE CM... Q4154
$62.8K
#598
INTEGRA MATRIX** Q4108
$61.9K
Total claims — #768 of 824
#763
ALDURAZYME J1931
25
#764
ESPEROCT J7204
25
#765
ACTEMRA(Q0249) Q0249
25
#766
INTEGRA MATRIX** Q4108
25
#767
EPINEPHRINE J0166
24
#768
HEPAGAM B(J1573) J1573
24
#769
YUTIQ J7314
24
#770
GAMIFANT J9210
24
#771
COMBOGESIC IV J0138
23
#772
CEFAZOLIN SODIUM(J06... J0688
23
#773
DAPTOMYCIN-0.9% NACL J0874
23
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $68.1K | 16 | 24 | $4,254.05 | $2,836.03 |
| 2025 (Q1-Q4) | $198.7K | 25 | 75 | $7,947.83 | $2,649.28 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk
2 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J1573 billing FAQ
What is HCPCS code J1573?
J1573 is a HCPCS Level II J-code used to bill Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J1573?
One unit of J1573 represents 0.5 ML. Report the number of units equal to the dose administered divided by 0.5 ML.
How many units of J1573 should I bill?
Divide the dose administered by the code's unit size (0.5 ML) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J1573?
The Medicare Part B payment limit is $65.610 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $64.298 per unit. Payment limits are revised quarterly.
Which NDCs bill under J1573?
2 NDCs currently map to J1573 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J1573 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.